Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

72
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
72
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

266
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
266
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

635
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
635
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

253
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
253
Crossover Experiments01:16

Crossover Experiments

4.3K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.3K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

90
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
90

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validation of a novel cognitive-functional outcome measure optimized for early Alzheimer's Disease: Evidence from the VIVA-MIND trial.

The journal of prevention of Alzheimer's disease·2026
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

The MMSE can yield biased and imprecise estimates of change: A novel IRT analysis of latent change scores from the A4 clinical trial.

Psychological assessment·2025
Same author

Implications of practice effects for the design of Alzheimer clinical trials.

Alzheimer's & dementia (New York, N. Y.)·2025
Same author

A Canonical Correlation Approach Towards Identifying Latent Neurofeedback Responses in Patients with Schizophrenia.

Applied psychophysiology and biofeedback·2025
Same author

α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease.

Neurology·2025
Same journal

Comparison of Methods for Clustered Data Analysis in a Non-Ideal Situation: Results from an Evaluation of Predictors of Yellow Fever Vaccine Refusal in the Global TravEpiNet (GTEN) Consortium.

International journal of statistics in medical research·2025
Same journal

High-Dimensional Fixed Effects Profiling Models and Applications in End-Stage Kidney Disease Patients: Current State and Future Directions.

International journal of statistics in medical research·2024
Same journal

Optimal Weighting of Preclinical Alzheimer's Cognitive Composite (PACC) Scales to Improve their Performance as Outcome Measures for Alzheimer's Disease Clinical Trials.

International journal of statistics in medical research·2024
Same journal

The Use of Putative Dialysis Initiation Time in Comparative Outcomes of Patients with Advanced Chronic Kidney Disease: Methodological Aspects.

International journal of statistics in medical research·2023
Same journal

Fixed Effects High-Dimensional Profiling Models in Low Information Context.

International journal of statistics in medical research·2022
Same journal

Multiple Imputation of Missing Race and Ethnicity in CDC COVID-19 Case-Level Surveillance Data.

International journal of statistics in medical research·2022
See all related articles

Related Experiment Video

Updated: Nov 20, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.9K

Power Calculations for Two-Wave, Change from Baseline to Follow-up Study Designs.

M Colin Ard1, Steven D Edland1,2

  • 1Department of Neuroscience, University of California San Diego, La Jolla, California.

International Journal of Statistics in Medical Research
|January 25, 2021
PubMed
Summary
This summary is machine-generated.

Sample size calculations for longitudinal studies can be inaccurate. New formulas are derived to provide conservative estimates, ensuring adequate power when study assumptions are violated.

Keywords:
Clinical TrialCompound SymmetryPhase 2Phase IIRate of ChangeSample Size

More Related Videos

Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans
08:25

Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans

Published on: May 19, 2016

11.0K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Related Experiment Videos

Last Updated: Nov 20, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.9K
Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans
08:25

Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans

Published on: May 19, 2016

11.0K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Quantitative Trait Analysis

Background:

  • Two-wave longitudinal studies commonly use quantitative traits as endpoints in early-phase clinical trials.
  • Accurate sample size calculations are crucial for study power but often rely on simplifying assumptions when longitudinal pilot data are scarce.
  • Standard sample size formulas assume equal variance at baseline and follow-up, an assumption frequently violated in practice.

Purpose of the Study:

  • To characterize the bias in sample size estimates when standard formula assumptions are not met.
  • To derive alternative, conservative formulas for sample size calculations in two-wave longitudinal studies.
  • To improve the reliability of power calculations for clinical trial designs.

Main Methods:

  • Analysis of bias in sample size estimates under violated assumptions.
  • Derivation of novel sample size formulas accounting for differing baseline and follow-up variances.
  • Evaluation of formula performance under various longitudinal study durations.

Main Results:

  • Standard sample size calculation methods can be anti-conservative when variance changes over time.
  • Bias in sample size estimates is significant when the follow-up interval differs from the pilot study duration.
  • The derived alternative formulas provide more conservative and reliable sample size estimates.

Conclusions:

  • Existing methods for sample size calculation in longitudinal studies may yield inadequate power due to violated assumptions.
  • The proposed conservative formulas offer a more robust approach to sample size determination for two-wave longitudinal studies.
  • Accurate sample size planning is essential for the successful progression of clinical trials.